Michael Pirovolakis
Tracked across 1 events · 6 articles · First seen May 27, 2026 · Last active May 27, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Michael Pirovolakis's diagnosis with SPG50 was the catalyst for the founding of Elpida Therapeutics and the development of gene therapy candidates.
May 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Michael Pirovolakis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard